Evidence map›Paper›PMID 34901148›Full record

ArticleFrontiers in molecular biosciences2021

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.

Xin Jin, Liwei Chen, Ning Zhou, Hong Ni, Lingling Zu, Jinling He, Lingqi Yang, Yifan Zhu, Xiaoyue Sun, Xiaojiang Li and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel Functional Features of cGMP Substrate Proteins IRAG1 and IRAG2.International journal of molecular sciences · 2023
    Review
  5. The 'omics of obesity in B-cell acute lymphoblastic leukemia.Journal of the National Cancer Institute. Monographs · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xin JinDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Liwei ChenDepartment of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Ning ZhouDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Hong NiDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Lingling ZuDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Jinling HeDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Lingqi YangDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Yifan ZhuDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Xiaoyue SunDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Xiaojiang LiDepartment of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Song XuDepartment of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
Tianjin Medical University General Hospital · CNFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

immune checkpoints (ICP)immune infiltrationLRMPlung adenocarcinomaprognosis

Identifiers

PMID34901148
PMCPMC8661541
OpenAlexW3217071065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.